{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-029373","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.815040+00:00","generated_at":"2026-06-05T06:43:54.089815+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Senseonics Q4 revenue $8.0M (+44% YoY); net loss $17.2M; 365-day FDA submission planned","bullets":["Q4 2023 revenue $8.0M vs $5.6M Q4 2022; full-year revenue $22.4M (+37% YoY).","Net loss $17.2M ($0.03/sh) in Q4 2023 vs net income $11.6M in Q4 2022; loss driven by derivative accounting.","Medicare expanded Eversense E3 coverage via three MACs; UnitedHealthcare coverage secured.","ENHANCE pivotal trial completed; 365-day system FDA submission expected in coming weeks; potential Q4 2024 launch.","First half 2024 revenue outlook ~$10M (+16% YoY); full-year guide deferred to Q2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-029373","json":"https://secwatch.observer/filing/0001104659-24-029373.json","markdown":"https://secwatch.observer/filing/0001104659-24-029373.md","text":"https://secwatch.observer/filing/0001104659-24-029373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924029373/0001104659-24-029373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924029373/tm247542d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:43:54.089815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"706a1137181150e084ecf34e91f7b81cbc348f9b","claim":"Senseonics Holdings, Inc. reported the quarter and year ended December 31, 2023 results: revenue $22.4 million, net income Net loss was $60.4 million, EPS $0.11 per share.","evidence_excerpt":"Total revenue for the fourth quarter of 2023 was $8.0 million compared to $5.6 million for the fourth quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924029373/0001104659-24-029373-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$22.4 million"},{"label":"Net income","value":"Net loss was $60.4 million"},{"label":"EPS","value":"$0.11 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"706a1137181150e084ecf34e91f7b81cbc348f9b","claim":"Senseonics Holdings, Inc. reported the quarter and year ended December 31, 2023 results: revenue $22.4 million, net income Net loss was $60.4 million, EPS $0.11 per share.","evidence_excerpt":"Total revenue for 2023 was $22.4 million compared to $16.4 million in 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924029373/0001104659-24-029373-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$22.4 million"},{"label":"Net income","value":"Net loss was $60.4 million"},{"label":"EPS","value":"$0.11 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}